Aquilon Pharmaceuticals
PrivateLast Round
VC Round
Jun 3, 2025
Total Funding Raised
$10.35M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aquilon Pharmaceuticals is a drug discovery company that develops pharmaceutical drugs for the treatment of pulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aquilon Pharmaceuticals Comparables
Compare Aquilon Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iconovo AB | 74% | |
| Transpire Bio Inc. | 73% | |
| Ligand Pharmaceuticals | 72% |
Aquilon Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 3, 2025 | ||||
| Grant | Aug 1, 2023 | ||||
| Grant | Feb 1, 2022 | ||||
| Debt | May 11, 2021 | ||||
| VC Round | Nov 30, 2018 | ||||
Seed | Oct 26, 2015 |
Key People
Founding team and executive leadership
Aquilon Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | VC Round |
| Wallonie Entreprendre | Grant |
| BioWin | Grant |
| Sambrinvest | VC Round |
| BeAngels | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 886% MoM, reaching 2.7K.
- Feb 23, 2025
Monthly visitors increased 275% MoM.
Aquilon Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aquilon Pharmaceuticals's valuation, stock price, and market status.
Is Aquilon Pharmaceuticals a public or private company?
Aquilon Pharmaceuticals is a private company.
What is the current stock price of Aquilon Pharmaceuticals?
Aquilon Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Aquilon Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aquilon Pharmaceuticals worth (valuation)?
Valuation information for Aquilon Pharmaceuticals is not publicly available.
Can I buy Aquilon Pharmaceuticals stock?
Aquilon Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aquilon Pharmaceuticals's last funding round?
Aquilon Pharmaceuticals's most recent funding round was VC Round on June 3, 2025.
Who are the main investors in Aquilon Pharmaceuticals?
Key investors in Aquilon Pharmaceuticals include Noshaq, Wallonie Entreprendre, BioWin, Sambrinvest, BeAngels.
Will Aquilon Pharmaceuticals IPO soon?
No public IPO plans have been announced for Aquilon Pharmaceuticals.
How can I track Aquilon Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Aquilon Pharmaceuticals's shares on secondary markets.